Sinobiopharma Announces Third Quarter 2010 Net Income of $0.9 Million
NANTONG CITY, China, April 19 /PRNewswire-Asia/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma" or "the Company), a fully integrated and highly innovative specialty pharmaceutical company engaged in the research and development, and the manufacture and marketing of biopharmace...
China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product
Basic Insurance to Cover 90 Percent of China's Urban Population of 600 Million by the End of 2010 NANTONG, China, Feb. 1 /PRNewswire-Asia/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC Bulletin Board: SNBP) is pleased to announce that the Chinese government has approved ...
Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
NANTONG, China, Jan. 25 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC Bulletin Board: SNBP) is pleased to announce that its production facility for solid dosage Perindopril has passed the required Chinese State Food and Drug Administration (SFDA) ins...
